نتایج جستجو برای: proms
تعداد نتایج: 715 فیلتر نتایج به سال:
The measurement of outcomes is key in evaluating healthcare or research interventions inflammatory bowel disease (IBD). In patient-centred care, patient-reported outcome measures (PROMs) are central to this evaluation. review, we provide an overview validated, adult disease-specific PROMs developed for use IBD. Our aim assist clinicians and researchers selection measure their patient cohort. Co...
BACKGROUND Validated patient-reported outcome measures (PROMs) of hip pain and function at the time of arthroscopy could be predictors of the final outcome. Little is known about how patient factors or pathologic intra-articular findings relate to hip pain or function at the time of surgery for those presenting with femoroacetabular impingement (FAI). PURPOSE To evaluate all patient and opera...
Describe a consecutive cohort of people with non-surgically treated ACL injury and evaluate correlations between functional performance patient reported outcome measures (PROMs). Cross-sectional. Sixty-eight individuals (38 males, 18–45 years old) 2–5 after injury. Tegner Activity Scale, International Knee Documentation Committee Subjective Form (IKDC-SKF), Anterior Cruciate Ligament Return to ...
OBJECTIVE To establish an international patient-reported outcomes (PROMs) study among prostate cancer survivors, up to 18 years postdiagnosis, in two countries with different healthcare systems and ethical frameworks. DESIGN A cross-sectional, postal survey of prostate cancer survivors sampled and recruited via two population-based cancer registries. Healthcare professionals (HCPs) evaluated ...
OBJECTIVES To present the baseline patient-reported outcome measures (PROMs) in the Prostate Testing for Cancer and Treatment (ProtecT) randomized trial comparing active monitoring, radical prostatectomy and external-beam conformal radiotherapy for localized prostate cancer and to compare results with other populations. MATERIALS AND METHODS A total of 1643 randomized men, aged 50-69 years an...
Dupilumab was approved in the EU 2017 for treatment of moderate-to-severe atopic dermatitis (AD). The good therapeutic response described clinical trials has yet to be confirmed everyday care settings. German registry TREATgermany is largest European patients with moderate severe AD more than 1,400 currently (May 2022) enrolled. Patients are prospectively monitored and course, treatment, patien...
OBJECTIVES While cognitive impairment is frequently reported in HIV-positive individuals and has historically been associated with poorer functional outcomes, the associations between cognitive impairment and patient-reported outcome measures (PROMs) in contemporary cohorts are unclear. METHODS We tested cognitive function using a computerized battery (CogState™ ) in 290 HIV-positive and 97 H...
OBJECTIVES To evaluate the feasibility of using patient-reported outcome measures (PROMs) for long-term conditions (LTCs) in primary care. DESIGN A cohort postal survey conducted from September 2010 to April 2012. SETTING Primary care practices (n=33) in London and the North-West of England. PARTICIPANTS 4484 patients with a diagnosis of asthma, chronic obstructive pulmonary disease, diab...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید